ATE66151T1 - Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen. - Google Patents

Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen.

Info

Publication number
ATE66151T1
ATE66151T1 AT86115016T AT86115016T ATE66151T1 AT E66151 T1 ATE66151 T1 AT E66151T1 AT 86115016 T AT86115016 T AT 86115016T AT 86115016 T AT86115016 T AT 86115016T AT E66151 T1 ATE66151 T1 AT E66151T1
Authority
AT
Austria
Prior art keywords
preparation
chem
pepsin
immunoglobulins
formula
Prior art date
Application number
AT86115016T
Other languages
English (en)
Inventor
Guido Gazzei
Aldo Giannozzi
Andrea Valeri
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Application granted granted Critical
Publication of ATE66151T1 publication Critical patent/ATE66151T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/091—Phenol resins; Amino resins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/098—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer formed in the presence of the enzymes or microbial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT86115016T 1985-11-08 1986-10-29 Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen. ATE66151T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22766/85A IT1186766B (it) 1985-11-08 1985-11-08 Metodo per la preparazione di immunoglobuline per uso endovenoso
EP86115016A EP0221505B1 (de) 1985-11-08 1986-10-29 Verfahren zur Herstellung von intravenös geeigneten Immunoglobulinen

Publications (1)

Publication Number Publication Date
ATE66151T1 true ATE66151T1 (de) 1991-08-15

Family

ID=11200219

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86115016T ATE66151T1 (de) 1985-11-08 1986-10-29 Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen.

Country Status (11)

Country Link
EP (1) EP0221505B1 (de)
JP (1) JPH07121876B2 (de)
AT (1) ATE66151T1 (de)
AU (1) AU6427886A (de)
CA (1) CA1306964C (de)
DE (1) DE3680860D1 (de)
ES (1) ES2033231T3 (de)
GR (1) GR3002931T3 (de)
IL (1) IL80547A0 (de)
IT (1) IT1186766B (de)
ZA (1) ZA868271B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465950B (sv) * 1989-10-23 1991-11-25 Medinvent Sa Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
US5354461A (en) * 1991-02-20 1994-10-11 Eisai Co., Ltd. Packings combining protein to a support via a spacer
CA2061519C (en) * 1991-02-20 2004-05-18 Naoki Asakawa Packings combining protein to a support via a spacer
EP0835880A1 (de) * 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664496A5 (de) * 1982-05-31 1988-03-15 Mochida Pharm Co Ltd Material zur entfernung von immunkomplexen aus dem blut oder aus plasma.

Also Published As

Publication number Publication date
EP0221505A2 (de) 1987-05-13
IT1186766B (it) 1987-12-16
GR3002931T3 (en) 1993-01-25
DE3680860D1 (de) 1991-09-19
JPH07121876B2 (ja) 1995-12-25
IL80547A0 (en) 1987-02-27
IT8522766A0 (it) 1985-11-08
EP0221505B1 (de) 1991-08-14
ZA868271B (en) 1987-06-24
CA1306964C (en) 1992-09-01
EP0221505A3 (en) 1988-05-04
JPS62114919A (ja) 1987-05-26
AU6427886A (en) 1987-05-14
ES2033231T3 (es) 1993-03-16

Similar Documents

Publication Publication Date Title
SE8301395D0 (sv) Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
DE3483869D1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
ATE135712T1 (de) Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung
KR900007861A (ko) 스핀고이드 부분에서 반응성 그룹을 갖는 글리코스핀고리피드, 이의 제조방법 및 이를 커플링시켜 수득한 강글리오사이드 유도체
ATE40391T1 (de) Verfahren zur herstellung von triazin- oder sowohl triazin- als oxazolingruppen enthaltenden vinylesterharzen.
SE8505920D0 (sv) New protein and its use
ATE66151T1 (de) Verfahren zur herstellung von intravenoes geeigneten immunoglobulinen.
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
DE69312566D1 (de) Verfahren zur Herstellung von Alkylpolyglukosiden
ATE41426T1 (de) Verfahren zur herstellung von triacetoxysilanen aus tris(amino)silanen.
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
DE68925951D1 (de) Chemisches Verfahren zur Herstellung des Antibiotikums L 17392 (Deglukoteicoplanin) und dessen Salze
ATE87906T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
ATE62235T1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
ATE58371T1 (de) Ester der 0(2,6dichlorphenylamino)phenylessigs|ure und ein verfahren zur deren herstellung.
JPS5599072A (en) Production of artificial antigen containing choline residue
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.
DE69017771D1 (de) Thymopentin-Analoge mit allen umgekehrten Verbindungen, Verfahren zur deren Herstellung und deren Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen.
PT87064A (pt) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
FR2611743B1 (fr) Procede pour la production de l-aminoacides ou d'acide 5'-inosinique par fermentation
KR870004708A (ko) 정맥투여용으로 적합한 면역 글로블린의 제조방법
ES2000879A6 (es) Un procedimiento para preparar una sal de acido inorganico de cloruro de n-(1(s)-etoxicarbonil-3-fenilpropil)-l-alanilo
IT1216685B (it) 1,2_di_0_acetil glicero fosfato di l_carnitina e degli esteri della carnitina procedimento per la sua preparazione e formulazioni farmaceutiche che li contengono.
IT1216683B (it) 2_0_acetil glicerolo_1,3_di fosfato di l_carnitina e degli esteri della l_carnitina, procedimentoperla sua preparazione e formulazionei farmaceutiche che li contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee